ResMed Story Overview

RMD -- USA Stock  

USD 106.81  1.12  1.04%

Macroaxis does not monitor all media channels or aggregates social signals for ResMed. But even though we do not provide professional-grade financial sentiment analysis on ResMed, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for ResMed. Additionally take a look at ResMed Hype Analysis, ResMed Correlation and ResMed Performance.
Payment of 4027 shares by Don Darkin of ResMed subject to Rule 16b-3
Filed transaction by Resmed Inc officer. Payment of exercise price or tax liability by delivering or withholding securities

ResMed Inc insider trading alert for payment of resmed common stock by Don Darkin, Pres. SDB SBU, on January 3, 2018. This event was filed by Resmed Inc with SEC on 2012-11-13. SEC Form: Changes in beneficial ownership. Don Darkin is currently serves as president - sleep-disordered breathing strategic business unit of ResMed Inc

Cash Floor Correlation

Click cells to compare fundamentals   View All Correlations

Story Momentum

This article from MacroaxisInsider published on 03 of January contributed to the next trading period price escalation.The trading delta at closing time to the next next day price was 0.14% . The trading delta at closing time when the story was published to current price is 24.09% .

Similar stores for ResMed

a day ago at www.macroaxis.com 
Exercise or conversion by John Wareham of 12000 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
few days ago at www.macroaxis.com 
Sale by Brett Sandercock of 2000 shares of ResMed
Macroaxis News
Filed transaction by Resmed Inc officer. General open market or private sale of non-derivative or derivative security
over a week ago at www.macroaxis.com 
Exercise or conversion by Smith Adrian M of 20000 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
over a week ago at http://colbypost.com 
ResMed Inc. Momentum in Focus as Target Weight For Portfolio Reaches 0.07000
news
Colby PostFull coverage
over two weeks ago at www.macroaxis.com 
Acquisition by Michael Farrell of 27199 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3
over two weeks ago at www.macroaxis.com 
ResMed exotic insider transaction detected
Macroaxis News
Filed transaction by Resmed Inc director. Unconventional Insider trading
over two weeks ago at www.macroaxis.com 
Acquisition by Christopher Roberts of 2442 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc director. Grant, award or other acquisition pursuant to Rule 16b-3
over three weeks ago at www.macroaxis.com 
Exercise or conversion by Rich Sulpizio of 28403 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
over three weeks ago at www.macroaxis.com 
Exercise or conversion by Brett Sandercock of 4000 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
over a month ago at http://danversrecord.com 
Resmed Inc Heading in the Right Direction
news
Danvers RecordFull coverage
over a month ago at www.macroaxis.com 
ResMed exotic insider transaction detected
Macroaxis News
Filed transaction by Resmed Inc director. Unconventional Insider trading
over two months ago at http://flintdaily.com 
Chesapeake Granite Wash Trust Reaches 1.23 1 Year Low ResMed Inc. Had 4 Analysts Last Week
news
FlintDaily.comFull coverage
over three months ago at www.macroaxis.com 
Exercise or conversion by Jacobsen Stein of 12000 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Did you try this?

Run Portfolio Backtesting Now
   

Portfolio Backtesting

Avoid under-diversification and over-optimization by backtesting your portfolios
All  Next Launch Portfolio Backtesting

Return On Asset

Return On Asset Comparative Analysis
  Return On Asset 
      ResMed Comparables 
ResMed is currently regarded as top stock in return on asset category among related companies. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Peers

ResMed Related Equities
DXCM  1.09 %   
0%
48.0%
XRAY  0.40 %   
0%
17.0%
VAR  0.20 %   
0%
8.0%
RMD  1.04 %   
45.0%
0%
DGX  1.18 %   
51.0%
0%
BSX  1.2 %   
52.0%
0%
SYK  1.43 %   
62.0%
0%
TFX  1.56 %   
68.0%
0%
HOLX  1.75 %   
77.0%
0%
COO  2.27 %   
100.0%
0%
Additionally take a look at ResMed Hype Analysis, ResMed Correlation and ResMed Performance. Please also try Equity Analysis module to research over 250,000 global equities including funds, stocks and etfs to find investment opportunities.